Mass Spectrometry-based Metabolomics in Translational Research
- PMID: 33834448
- DOI: 10.1007/978-981-33-6064-8_19
Mass Spectrometry-based Metabolomics in Translational Research
Abstract
Metabolomics is the systematic study of metabolite profiles of complex biological systems, and involves the systematic identification and quantification of metabolites. Metabolism is integrated with all biochemical reactions in biological systems; thus metabolite profiles provide collective information on biochemical processes induced by genetic or environmental perturbations. Transcriptomes or proteomes may not be functionally active and not always reflect phenotypic variations. The metabolome, however, consists of the biomolecules closest to the phenotype of living organisms, and is often called the molecular phenotype of biological systems. Thus, metabolome alterations can easily result in disease states, providing important clues to understand pathophysiological mechanisms contributing to various biomedical symptoms. The metabolome and metabolomics have been emphasized in translational research related to biomarker discovery, drug target discovery, drug responses, and disease mechanisms. This review describes the basic concepts, workflows, and applications of mass spectrometry-based metabolomics in translational research.
Keywords: Mass spectrometry; Metabolome; Metabolomics; Molecular phenotype; Translational research.
Similar articles
-
Understanding Metabolomics in Biomedical Research.Endocrinol Metab (Seoul). 2016 Mar;31(1):7-16. doi: 10.3803/EnM.2016.31.1.7. Endocrinol Metab (Seoul). 2016. PMID: 26676338 Free PMC article. Review.
-
Metabolomics for Clinical Biomarker Discovery and Therapeutic Target Identification.Molecules. 2024 May 8;29(10):2198. doi: 10.3390/molecules29102198. Molecules. 2024. PMID: 38792060 Free PMC article. Review.
-
FUNCTIONAL METABOLOMICS DECIPHER BIOCHEMICAL FUNCTIONS AND ASSOCIATED MECHANISMS UNDERLIE SMALL-MOLECULE METABOLISM.Mass Spectrom Rev. 2020 Sep;39(5-6):417-433. doi: 10.1002/mas.21611. Epub 2019 Nov 4. Mass Spectrom Rev. 2020. PMID: 31682024 Review.
-
[Gastroenterological Cancer Diagnosis by Metabolomics-Discovery of Pancreatic Cancer Biomarker].Rinsho Byori. 2015 Apr;63(4):450-6. Rinsho Byori. 2015. PMID: 26536778 Review. Japanese.
-
Cell metabolomics.OMICS. 2013 Oct;17(10):495-501. doi: 10.1089/omi.2012.0090. Epub 2013 Aug 29. OMICS. 2013. PMID: 23988149 Free PMC article. Review.
Cited by
-
Amino acid analysis as a method of discovering biomarkers for diagnosis of diabetes and its complications.Amino Acids. 2023 May;55(5):563-578. doi: 10.1007/s00726-023-03255-8. Epub 2023 Apr 17. Amino Acids. 2023. PMID: 37067568 Review.
-
Advances and Trends in Omics Technology Development.Front Med (Lausanne). 2022 Jul 1;9:911861. doi: 10.3389/fmed.2022.911861. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35860739 Free PMC article. Review.
-
Patterns of infant fecal metabolite concentrations and social behavioral development in toddlers.Pediatr Res. 2024 Jul;96(1):253-260. doi: 10.1038/s41390-024-03129-z. Epub 2024 Mar 20. Pediatr Res. 2024. PMID: 38509226 Free PMC article.
-
Metabolomic profiles of ovariectomized mice and their associations with body composition and frailty-related parameters in postmenopausal women.J Endocrinol Invest. 2024 Oct;47(10):2551-2563. doi: 10.1007/s40618-024-02338-x. Epub 2024 Mar 17. J Endocrinol Invest. 2024. PMID: 38493245
-
Integrated network pharmacology and metabolomics to reveal the mechanism of Pinellia ternata inhibiting non-small cell lung cancer cells.BMC Complement Med Ther. 2024 Jul 11;24(1):263. doi: 10.1186/s12906-024-04574-3. BMC Complement Med Ther. 2024. PMID: 38992647 Free PMC article.
References
-
- Amal AL, Funka K, Skapars R, Sivins A, Ancans G, Liepniece-Karele I, Kikuste I, Lasina I, Haick H (2015) Detection of precancerous gastric lesions and gastric cancer through exhaled breath. Gut 65:1–8
-
- Aubin MC, Lajoie C, Clement R, Gosselin H, Calderone A, Perrault LP (2008) Female rats fed a high-fat diet were associated with vascular dysfunction and cardiac fibrosis in the absence of overt obesity and hyperlipidemia: therapeutic potential of resveratrol. J Pharmacol Exp Ther 325(3):961–968 - PubMed - DOI - PMC
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources